BrainCheck, the leading FDA Class II digital cognitive assessment and care platform, has been awarded a $500,000 SBIR Phase I grant (R43AG094410) from the National Institutes of Health (NIH) to ...
Intellicule has received a $217,941 NIH SBIR Phase I grant to develop advanced deep-learning software for biomolecular ...
State-of-the-art technology could accelerate novel drug development, advance precision medicine Intellicule founders Purdue ...
MIAMI, Sept. 26, 2025 (GLOBE NEWSWIRE) -- ADvantage Therapeutics, Inc., a biotechnology company developing novel therapies for neurodegenerative diseases, today announced it has been awarded a $2.5 ...
BOTHELL, Wash., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) announces it has received a Small Business Innovation Research (SBIR) Phase I ...
IMVARIA’s development of a new test for more accurate malignancy assessment in chest CTs, building on the success of Fibresolve and advancing healthcare AI innovation IMVARIA Inc., a health tech ...
NIH funding supports a clinical trial of Storii’s telephone-based memoir service that reduces isolation, improves mental health, and connects rural older adults With just a telephone call, we’re ...
What is the effectiveness of the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs at the National Institutes of Health (NIH)? An ad hoc committee will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results